Global Medical Nitrous Oxide Delivery Systems Market – Restraints
The major factor restraining the growth of the medical nitrous oxide delivery systems market is stringent rules and regulation over the possession, transport and use of nitrous oxide delivery systems. Centre for Drug Evaluation and Research and the U.S. Food and Drug Administration regulate the use of medical gases and their associated equipment and the guidelines regulated by them specify the use and administration of nitrous oxide delivery systems.
Health workers who are exposed to nitrous oxide delivery systems for a long period of time can suffer from skin allergy. According to the United States Environmental Protection Agency, in 2018, nitrous oxide delivery systems (N2O) accounted for about 6.5% of all U.S. greenhouse gas emissions from human activities such as agriculture, fuel combustion, wastewater management, and industrial processes (medical and non-medical) which increasing the amount of N2O in the atmosphere. These factors are expected to restrain the global medical nitrous oxide delivery systems market growth during the forecast period.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients